Crystal Equity Research12 Sep 2023 07:57
For those that missed it, here is their updated research report, dated 29 August 2023. It is very much worth a detailed read:-
https://crystalequityresearch.com/2023/08/29/update-report-iq-ai-ltd-iqai-iqaif-3/
(Note, the GE Healthcare deal is based on revenue share, so making our revenue stream easier to define. This in part, will explain why Crystal is predicting positive cashflow in 2024.)
"In our view, the economics of the GE Healthcare deal is particularly attractive. Imaging Biometrics will receive revenue share based on installed base rather than procedures, providing a predictable annual revenue stream. The deal will apply to sites where GE Healthcare has already installed systems and well as new systems scheduled for installation. GE Healthcare is regarded as the second largest player in the diagnostic imaging market with particular strength in the computed tomography (CT) scanning and medical resonance (MR) imaging segments."